Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Vmn1r173 Activators

Vmn1r173 is a vomeronasal type 1 receptor that plays a pivotal role in the detection and transduction of pheromonal signals, contributing to social and reproductive behaviors in various species. This G protein-coupled receptor (GPCR) is primarily expressed in the vomeronasal organ, where it functions as a molecular sensor for chemosensory cues. The activation of Vmn1r173 is intricately linked to the modulation of the cyclic adenosine monophosphate (cAMP) signaling pathway. When exposed to specific chemical stimuli, such as the ones detailed in the provided table, Vmn1r173 undergoes conformational changes, initiating a cascade of intracellular events.

Forskolin, for instance, directly activates Vmn1r173 by interacting with adenylyl cyclase, stimulating cAMP production. This heightened cAMP level serves as a critical second messenger, triggering downstream protein kinase A (PKA) activation. Similarly, compounds like Isoproterenol and Rolipram play crucial roles in Vmn1r173 activation. Isoproterenol, a beta-adrenergic agonist, directly binds to the receptor, initiating GPCR signaling and elevating cAMP levels, ultimately leading to PKA activation. On the other hand, Rolipram indirectly activates Vmn1r173 by preventing cAMP degradation through phosphodiesterase inhibition, resulting in enhanced GPCR signaling and subsequent PKA activation. These mechanisms highlight the intricate interplay of signaling molecules and cellular pathways in the activation of Vmn1r173. Beyond the direct activators, the receptor is also influenced by compounds like SQ22536, a selective adenylyl cyclase inhibitor, and H89, a PKA inhibitor. SQ22536 indirectly affects Vmn1r173 by impeding cAMP production, altering the balance of the GPCR signaling pathway and modulating cellular responses. H89, on the other hand, indirectly influences Vmn1r173 by suppressing PKA activity, interrupting downstream signaling and affecting receptor activation. Understanding these intricate details provides a comprehensive view of the biochemical and cellular processes involved in Vmn1r173 activation. While the exact physiological implications of these activations in behavioral responses are still an area of ongoing research, the detailed exploration of these chemical modulators offers valuable insights into the molecular basis of chemosensory signaling mediated by Vmn1r173.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram, a phosphodiesterase inhibitor, indirectly activates Vmn1r173 by preventing cAMP degradation. Elevated cAMP levels enhance GPCR signaling, leading to increased PKA activity and, consequently, the activation of Vmn1r173 and associated cellular responses.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Isoproterenol, a beta-adrenergic agonist, directly activates Vmn1r173 by binding to its receptor, initiating GPCR signaling. This leads to increased cAMP production, activating downstream PKA and ultimately resulting in the activation of Vmn1r173 and related cellular responses.

SQ 22536

17318-31-9sc-201572
sc-201572A
5 mg
25 mg
$95.00
$363.00
13
(1)

SQ22536, an adenylyl cyclase inhibitor, inhibits cAMP production, thereby indirectly influencing Vmn1r173 activation. By modulating the GPCR signaling pathway, it hinders downstream PKA activity, affecting the overall cellular responses associated with Vmn1r173.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$57.00
$159.00
$275.00
$678.00
37
(1)

Prostaglandin E2 (PGE2), a signaling molecule, indirectly activates Vmn1r173 by binding to its receptor and activating GPCR signaling. This leads to enhanced cAMP levels, triggering downstream PKA activity, resulting in the activation of Vmn1r173 and related cellular responses.

Iloprost

78919-13-8sc-205349
sc-205349A
500 µg
1 mg
$155.00
$269.00
(0)

Iloprost, a prostacyclin analog, indirectly activates Vmn1r173 by engaging its receptor and initiating GPCR signaling. This leads to increased cAMP levels, activating downstream PKA and ultimately resulting in the activation of Vmn1r173 and associated cellular responses.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Propranolol, a non-selective beta-blocker, indirectly influences Vmn1r173 by blocking beta-adrenergic receptors. This inhibits GPCR signaling, reducing cAMP levels and suppressing downstream PKA activity, ultimately influencing the cellular responses associated with Vmn1r173.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX, a phosphodiesterase inhibitor, indirectly activates Vmn1r173 by preventing cAMP degradation. Elevated cAMP levels enhance GPCR signaling, leading to increased PKA activity and, consequently, the activation of Vmn1r173 and associated cellular responses.